Drug Shortage Report for APO-LAMIVUDINE HBV

Last updated on 2020-02-25 History
Report ID 100278
Drug Identification Number 02393239
Brand name APO-LAMIVUDINE HBV
Common or Proper name LAMIVUDINE
Company Name APOTEX INC
Active Ingredient(s) LAMIVUDINE
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-02
Estimated end date 2020-03-06
Actual end date 2020-02-21
Shortage status Resolved
Updated date 2020-02-25
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-02-25 French Compare
v5 2020-02-25 English Compare
v4 2020-01-31 French Compare
v3 2020-01-31 English Compare
v2 2019-12-05 French Compare
v1 2019-12-05 English Compare